Intratracheal budesonide combined with surfactant for respiratory distress syndrome in preterm infants: A randomized clinical trial.
BackgroundBronchopulmonary dysplasia (BPD) remains a major cause of morbidity among preterm infants with respiratory distress syndrome (RDS). Intratracheal budesonide combined with surfactant may reduce pulmonary inflammation and improve neonatal outcomes.MethodsIn this randomized clinical trial, 160 preterm infants (g...